How to Ensure That You Receive ALL the Money Your Tasigna Case Deserves
Tasigna lawsuits are currently being filed against the makers of the cancer drug Tasigna. Tasigna has been linked to a dangerous condition called atherosclerosis. Parker Waichman’s experienced Cancer Drug and Atherosclerosis Injury Attorneys are helping victims of Tasigna injuries receive full compensation for the drug manufacturer’s failure to warn about the risks associated with the drug.
Because of the wrongful conduct of this manufacturer, cancer patients are now faced with another serious medical condition caused by the very drug that was supposed to treat them. We will stand up to the manufacturer and fight for your legal rights.
Tasigna Properties and Purpose
Tasigna is a prescription medication belonging to a class of drugs calls kinase inhibitors. It is manufactured by Novartis Pharma Stein AG and Novartis Pharmaceuticals Corporation and is indicated for treatment of a specific kind of cancer in adults: chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML).
This is a cancer in which an abnormal chromosome, called the Philadelphia chromosome, produces too many white blood cells that slowly crowd out healthy white blood cells and prevent the cells from functioning normally. It is a cancer that affects both blood and bone marrow.
Tasigna is designed to treat Ph+ CML by inhibiting the specific protein produced by the Philadelphia chromosome that is responsible for overproduction of white blood cells. It is a tablet to be taken orally with a timed food regimen that standardly comes in 400 mg or 200 mg doses.
Tasigna Side Effects and Injuries
Clinical studies show that Tasigna leads to a complication called atherosclerosis or thickening and blocking of the arteries. Your arteries are like the pipes in your body, helping blood and oxygen travel to cells and organs.
When plaque (deposits of fatty matter, cellular waste, and clotting material) builds up in your arteries, your cells and organs cannot get the amount of blood flow and oxygen they need. Arterial blockage can then lead to a number of extremely serious complications, depending on the location of the blockage, including:
- Coronary artery disease (affecting the heart)
- Carotid artery disease (affecting the neck and brain)
- Angina (affecting the chest and heart)
- Peripheral artery disease (affecting the extremities, especially the legs)
- Chronic kidney disease (affecting the kidneys)
In turn, these complications from certain blocked arteries and decreased blood flow can cause the following severe events to occur:
- Heart attack
- Tissue decay and necrosis
- Kidney failure
The prospect any person having to deal with these potential conditions is tragic, but when they occur from a drug that was supposed to help people with advanced cancer, it is utterly devastating. Parker Waichman LLP is taking Tasigna cases because we want to hold Novartis responsible for these traumatic injuries, particularly in light of its outrageous profits-motivated conduct.
Novartis Motivated by Greed
The rise of Tasigna came upon the fall of Novartis’ other popular CML cancer treatment drug, called Gleevec. Gleevec, also a kinase inhibitor, was a huge moneymaker for Novartis, generating about $5 billion in revenue for the corporation in 2015.
But toward the end of 2015, its patent on the drug was set to expire, meaning it would no longer control the exclusive right to sell the drug starting in 2016. Generic sales of the drug’s active ingredient (imatinib) were expected to cause a major financial hit to the tune of millions or even billions of dollars.
Without the ability to stop generic sales, Novartis did the next-best thing: promoted its own competitor to Gleevec. Leading up to the expiration of its Gleevec patent, Novartis started marketing Tasigna as a superior treatment to Gleevec, even putting on the Tasigna label that it was indicated for patients who seemed resistant to or nonresponsive to imatinib treatments.
Novartis unbelievably went as far as paying specialty pharmacies to recommend Tasigna to Medicare and Medicaid patients who were trying to fill prescriptions for other drugs (potentially generic imatinib) and to downplay the side effects of Tasigna to patients considering switching drugs.
Novartis agreed to pay $390 million in 2015 to settle charges from the U.S. Department of Justice that it was engaging in an illegal kickback scheme with specialty pharmacies concerning six drugs, one of which was Tasigna.
The whole time that it was promoting Tasigna over Gleevec and paying pharmacies to peddle its drug to innocent cancer patients, it knew the drug was dangerous. This inexcusable display of greed is why Parker Waichman’s attorneys are filing lawsuits against Novartis. Novartis knew of the risk of atherosclerosis and related complications and did nothing to warn U.S. doctors or consumers.
No Atherosclerosis Warning on U.S. Tasigna Label
Drug manufacturers have a legal obligation to make sure their medications are safe, and they have an ongoing duty to provide doctors and patients adequate warnings about the risks associated with their drugs. Regarding atherosclerosis, Novartis took some action in Canada but has yet to provide any warnings in the United States.
On April 9, 2013, Health Canada (the Canadian equivalent to the U.S. Food and Drug Administration) released a statement to health care providers alerting them to the potential for Tasigna to cause atherosclerosis-related diseases.
The statement indicated that a recent study correlated Tasigna use with atherosclerosis-related diseases, finding arterial blockage and related injuries in up to 6 percent of patients studied. Health Canada also stated that 277 cases of atherosclerosis with Tasigna use had been identified in the Novartis global safety database.
At the same time that it released this statement, Health Canada announced changes would be made to the Tasigna drug label to reflect these findings and the potential risk for atherosclerosis with Tasigna use.
To date, the U.S. Food and Drug Administration (FDA) has made no statements with regard to Tasigna and atherosclerosis, nor has Novartis taken any steps to change its U.S. Tasigna drug label.
Because of the widespread failures of Novartis and the U.S. pharmaceutical system, already vulnerable patients looking for a cancer cure are at risk for serious health conditions and death.
Parker Waichman LLP will aggressively seek compensation on behalf of people injured by Tasigna and families who have lost loved ones to Tasigna injuries. Contact our offices to learn more about the Tasigna case-filing process and your options for legal recourse.
Statutes of Limitations on Tasigna Claims
A statute of limitations is a time limit on filing a lawsuit imposed by state law. If you do not file a claim for injuries within the state’s set amount of time, your claim will expire, and you will never be able to file it. States create statutes of limitations to encourage plaintiffs to investigate their claims and act quickly to file any viable lawsuits.
Swifter action has the effect of preserving reliable evidence. For instance, witnesses you might call to testify will have stronger memories of the events in question if you go to trial within three years, rather than within 10 years.
If you file a claim sooner, it is also more likely that your medical records and pertinent business documents for your case will be available and retrievable. After so many years, medical facilities and businesses will destroy records to clear storage space. States further have an interest in making sure potential defendants do not have to prepare indefinitely for litigation.
Example Statute of Limitations Time Limits
The general statutes of limitations on product liability actions in these states are:
- New York – 3 years
- New Jersey – 2 years
- Florida – 4 years
These are conservative interpretations to some degree where states have “discovery rules” built into their statutes of limitations. Discovery rules have the effect of pausing the clock, allowing you time to discover the full extent of your injuries, and sometimes even why you were injured and by whom you were injured. Generally, New York does not recognize a discovery rule on product liability cases, but New Jersey and Florida do.
In cases like Tasigna, where the product in question is a drug you likely received in multiple doses, it can be very difficult to determine when the clock on your time window to file actually started running. The best way to find out the correct statute of limitations on your case is to work with an experienced Tasigna lawyer.
Parker Waichman’s attorneys diligently calculate statutes of limitations on all our Tasigna cases to be sure we will be able to complete your case investigation in time to file a lawsuit against Novartis.
Tasigna Claims Process
You know you have been injured by Tasigna, but you likely do not know where to begin in hiring legal representation. We know you have a lot to worry about already, so we keep our case intake process as easy as possible.
It starts with one phone call to our offices, during which you will be able to speak with a compassionate member of our legal staff, as well as one of Parker Waichman’s skilled Tasigna lawyers. They will explain the process to you, including the services we will be able to provide. Your Parker Waichman LLP team will do all of the following on your behalf:
- Gather detailed information about your cancer history, treatment, and prescription use of Tasigna;
- Order pharmacy records that show you used brand-name Tasigna and for how long you used it (a process we call establishing “proof of use” or “product identification”);
- Obtain medical records that document your cancer diagnosis, prescribing information, diagnosis of atherosclerosis or related condition and subsequent treatment;
- Contact medical experts and prescription drug industry experts to gain the best supportive opinions for your case;
- Calculate the statute of limitations or time limitation on filing your claim;
- Determine the proper venue for filing your claim;
- Draft a complaint and file the complaint in the appropriate court.
These steps describe just the work we will do leading up to case filing. Some of the hardest work will begin after that, including sorting through massive document production by the defendant. When you are going up against a giant pharmaceutical corporation like Novartis, you absolutely need lawyers who know what they’re doing.
This will no doubt be a difficult battle, but Parker Waichman LLP will not give up. We know how your injuries have affected your life, and we are determined to help you achieve the compensation you deserve.
Frequently Asked Questions
Many people who call us with potential Tasigna cases have questions about the drug and the lawsuits we are currently filing. Below you will find a few of the questions we hear most often, along with our answers.
What is Tasigna?
Tasigna is a prescription medication belonging to a class of drugs calls kinase inhibitors. It is used to treat chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML). This is a cancer in which an abnormal chromosome, called the Philadelphia chromosome, produces too many white blood cells. Tasigna is designed to treat Ph+ CML by inhibiting the specific protein produced by the Philadelphia chromosome that is responsible for overproduction of white blood cells.
Who Manufactures Tasigna?
Tasigna is manufactured by Novartis Pharma Stein AG and Novartis Pharmaceuticals Corporation. Novartis is a Swiss-based corporation that manufactures numerous prescription drugs, including a major Tasigna competitor called Gleevec.
Why are People Filing Tasigna Lawsuits?
Parker Waichman LLP is pursuing legal justice for people who took Tasigna and developed a condition called atherosclerosis. Atherosclerosis is the medical term for thickening of arterial walls or blockage of the arteries that can cause serious complications like heart attack, stroke, infection, gangrene, limb amputations, and death. Novartis failed to warn doctors and patients about the risks of atherosclerosis and atherosclerosis-related complications, even though it knew for numerous years about the connection between these conditions and Tasigna.
Has There Been a Tasigna Recall?
Despite the known potential for Tasigna to cause atherosclerosis and related diseases, the drug remains on the market. The FDA has not mandated a recall and has also made no statement regarding the connection between Tasigna and atherosclerosis. Tasigna’s drug label does, however, include information about other serious medical risks, including a “black box” warning (the highest possible drug warning) regarding the risk of sudden cardiac death while taking Tasigna.
If you believe you have been injured by Tasigna, don’t wait for the drug industry to make things right; demand justice by filing a claim for damages. Parker Waichman LLP can help you hold Novartis accountable for your injuries.
I’m Not Sure Whether I Took Tasigna. Can You Help Me?
We understand that during a stressful and complex cancer treatment regimen, you might try multiple drugs and methods. It can be difficult to keep track of the brand names or generic names of every drug you’re using, and we certainly don’t expect you to. If you took an oral tablet for treatment of Ph+ CML and developed an arterial blockage or arterial disease and related complications, contact our firm as soon as possible.
We will order your treatment records and pharmacy records, which will tell us for sure whether you used brand-name Tasigna. Our compassionate lawyers will then discuss your potential options for filing a lawsuit against Novartis.
How Can a Personal Injury Lawyer Help Me?
The attorneys at Parker Waichman LLP will aggressively seek compensation for every way you have been harmed by Tasigna. This includes not only compensation for the economic harms you have suffered, but also compensation for the pain and suffering you and your family have experienced. When you work with our firm to file a lawsuit against Novartis, we will seek all of the following types of damages on your behalf:
- Medical bills for the treatment you have received related to atherosclerosis or related conditions;
- Compensation for any medical treatment you will likely need in the future;
- Lost wages if you had to take time away from work because of your injuries and/or will need to take time away in the future because of your Tasigna injuries (including being permanently unable to go to work);
- Damages for the physical and mental pain and suffering you have experienced and will continue to experience in the future;
- Damages for lost support, companionship, society if you are filing a lawsuit on behalf of a deceased loved one who took Tasigna;
- Punitive damages, which have the effect of punishing the drug manufacturer, if the facts of the case warrant an award of these kinds of damages (usually reserved for egregious behavior on the part of the defendant).
It is clear that Novartis is motivated by money, so we intend to make the biggest impact possible on the corporation by seeking the highest possible damages for our clients.
We know a money award in any amount will never truly make up for what has happened to you, and we would never suggest it could. But we also understand that your injuries or the injuries of a loved one have placed a financial burden on you and your family, and you need relief from that strain.
You deserve to receive compensation from the parties who profited from your pain. Parker Waichman LLP can help you achieve the justice you need. Contact our firm today to discuss your options.
Speak With One Of Our Tasigna Personal Injury Attorneys Today
Parker Waichman LLP is currently offering free confidential consultations on Tasigna cases. Our skilled product liability lawyers will listen to your story and investigate your case without a penny down. Even if we are unable to move forward with your case, you never have to worry about receiving a bill from us because we contract our cases on a contingency fee basis. That means if you do not receive compensation, neither do we.
You and your family have been through enough, and we understand how traumatic your cancer treatment and Tasigna injuries have been. We never want you to delay seeking deserved justice because you don’t think you can afford it. When you hire Parker Waichman, you will benefit from our decades litigating against major pharmaceutical corporations like Novartis while leaving the financial risk of the legal battle to us. We will take on this fight so you can focus on important things at home. Contact Parker Waichman LLP today to ask for more information about our free consultations and how we can help you and your family.
At Parker Waichman, we have a long history of achieving tremendous results for our clients. We are proud to say we have secured more than $2 billion in settlement awards and court verdicts for victims and their families, and we have earned a reputation for superior client advocacy. Fellow plaintiffs’ lawyers, defense lawyers, judges, and clients have placed Parker Waichman LLP among the top personal injury and product liability law firms in the country, which shows in the following honors and accolades we have received:
- 8 (out of a perfect 10) Rating by AVVO (a service that rates every attorney in the United States)
- “Preeminent Lawyers” AV Peer Review Rating (Martindale-Hubbell® – a company that, for more than 100 years, has rated attorneys across the United States and the world based on feedback from judges and their peers)
- Highest Ranking of “5 Dragons,” based on peer review by Lawdragon
- Listing in Best Lawyers Publication, determined by Extensive Peer Review
Parker Waichman LLP
At Parker Waichman LLP, we are dedicated to helping people and will advocate for fair compensation for your injuries. If you or a loved one used Tasigna for cancer treatment and subsequently developed atherosclerosis, contact our firm today for your free consultation by filling out our online form or by calling 1-800-YOURLAWYER (1-800-968-7529).
New York | Brooklyn | Queens | Long Island | New Jersey | Florida